These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2232062)
1. Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy. Vega GL; Grundy SM JAMA; 1990 Dec; 264(21):2759-63. PubMed ID: 2232062 [TBL] [Abstract][Full Text] [Related]
2. Comparison of lovastatin and gemfibrozil in normolipidemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM JAMA; 1989 Dec; 262(22):3148-53. PubMed ID: 2810673 [TBL] [Abstract][Full Text] [Related]
3. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil]. Gavelli MS; Vitaliano E; Rossi FG; Serra T; Santini G; Bernardi G Clin Ter; 1991 Jan; 136(1):31-8. PubMed ID: 1826871 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM Arch Intern Med; 1994 Jan; 154(1):73-82. PubMed ID: 8267492 [TBL] [Abstract][Full Text] [Related]
6. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM. Garg A; Grundy SM Diabetes; 1989 Mar; 38(3):364-72. PubMed ID: 2917701 [TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
8. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498 [TBL] [Abstract][Full Text] [Related]
9. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia. Bredie SJ; Westerveld HT; Knipscheer HC; de Bruin TW; Kastelein JJ; Stalenhoef AF Neth J Med; 1996 Aug; 49(2):59-67. PubMed ID: 8824106 [TBL] [Abstract][Full Text] [Related]
10. Management of primary mixed hyperlipidemia with lovastatin. Vega GL; Grundy SM Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864 [TBL] [Abstract][Full Text] [Related]
11. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526 [TBL] [Abstract][Full Text] [Related]
12. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia]. Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917 [TBL] [Abstract][Full Text] [Related]
13. Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia. Ramires JA; Mansur AP; Solimene MC; Maranhão R; Chamone D; da Luz P; Pileggi F Int J Cardiol; 1995 Feb; 48(2):115-20. PubMed ID: 7774989 [TBL] [Abstract][Full Text] [Related]
14. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM; Barnett MD; Wright JT; Proctor JP Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045 [TBL] [Abstract][Full Text] [Related]
15. Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome. Simo IE; Yakichuk JA; Ooi TC Atherosclerosis; 1993 Apr; 100(1):55-64. PubMed ID: 8318063 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Goldberg R; La Belle P; Zupkis R; Ronca P Am J Cardiol; 1990 Sep; 66(8):16B-21B. PubMed ID: 2206032 [TBL] [Abstract][Full Text] [Related]
17. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation. Zambón D; Ros E; Rodriguez-Villar C; Laguna JC; Vázquez M; Sanllehy C; Casals E; Sol JM; Hernández G Metabolism; 1999 Jan; 48(1):47-54. PubMed ID: 9920144 [TBL] [Abstract][Full Text] [Related]
18. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia. Bell DS Clin Ther; 1995; 17(5):901-10. PubMed ID: 8595642 [TBL] [Abstract][Full Text] [Related]
19. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias]. Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741 [TBL] [Abstract][Full Text] [Related]
20. A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia. D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC Am J Cardiol; 1992 Jan; 69(1):28-34. PubMed ID: 1729864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]